Core Viewpoint - Meirui New Materials (300848) announced that the company does not provide guarantees to entities outside the consolidated financial statements, nor does it have overdue debts related to guarantees, litigation guarantees, or guarantees resulting from adverse judgments [1] Group 1 - The company confirmed the absence of guarantees provided to off-balance sheet entities [1] - There are no overdue debts associated with guarantees [1] - The company does not have any litigation-related guarantees or guarantees that could lead to adverse judgments [1]

证券代码：300848 证券简称：美瑞新材 公告编号：2025-074 美瑞新材料股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 特别风险提示： 本次担保的对象为美瑞新材料股份有限公司（以下简称"公司"）的控股子公司美瑞 科技（河南）有限公司（以下简称"美瑞科技"），美瑞科技的资产负债率超过 70%，敬请 广大投资者注意投资风险。 一、担保情况概述 1、已审批通过的担保额度 公司于 2022 年 3 月 12 日、2022 年 4 月 8 日分别召开了第三届董事会第四次会议、2021 年年度股东大会，审议通过了《关于为子公司提供担保的议案》，同意公司对美瑞科技提 供不超过 8 亿元的担保额度，上述额度适用范围包括但不限于美瑞科技申请及办理各类贷 款、信用证、保函、银行承兑汇票、融资租赁等业务，自公司 2021 年年度股东大会审议通 过之日起 7 年内有效，在额度内可循环使用。具体内容详见公司于 2022 年 3 月 15 日在巨 潮资讯网（www.cninfo.com.cn）披露的《关于为子公司提供担保的公告》。 ...

Financial Performance - The company achieved a net profit of 39.12 million yuan in the first half of 2025, representing a year-on-year growth of 25.25% [2] - The net cash flow from operating activities reached 157 million yuan, indicating a healthy cash flow position [2] - As of June 2025, the company reported a cash balance of approximately 400 million yuan and held financial products worth about 310 million yuan [2] Product Development and Competitive Advantage - The company has developed a lightweight and high-rebound TPU foam product, which is primarily used in sports shoe midsoles, showing promising market prospects [3] - The core raw material for the TPU foam is HDI, which will enhance the competitive advantage of the product once the Henan project is operational [3] Specialty Amines Production - The company produces specialty amines including PNA, PPDA, and CHDA, which are essential for various chemical applications [4] - The production process utilizes a continuous chemical method, significantly reducing production costs due to stable raw material supply [4] - The high-end application fields for these products show broad development prospects due to their superior performance [4] Investment Projects - The projected after-tax internal rate of return for the 10,000-ton expandable thermoplastic polyurethane elastomer project is 39.68%, with a payback period of approximately 4.01 years [4] - The 30,000-ton water-based polyurethane project has an expected after-tax internal rate of return of 38.05% and a payback period of about 4.21 years [4] - Both projects commenced construction in December 2024 and are expected to be completed by the end of June 2026 [4] Future Capital Expenditure Plans - The company will consider its strategic planning, market conditions, industry trends, and actual funding needs for future capital expenditure [5]

Group 1: Capital Increase and Strategic Plans - The company plans to increase capital in its subsidiary, Meirui Technology, by approximately 349,999,999.61 RMB, raising registered capital by 250,680,418.00 RMB and capital reserve by 99,319,581.61 RMB, which will increase the holding ratio from 55.00% to 70.03% [2][3] - The capital increase aims to enhance Meirui Technology's capital strength, optimize its financial structure, alleviate liquidity pressure, and improve overall competitiveness [2][3] - The investment is part of a strategic layout to capture growth opportunities in the polyurethane industry and enhance profitability for the parent company [3] Group 2: Product Applications and Market Focus - The company will collaborate with mainstream industries for HDI-related products, including coatings, automotive paints, and industrial paints, while also focusing on emerging applications in polyurethane new materials [4] - Meirui Technology's specialty amine products include PNA, PPDA, and CHDA, which are essential for various chemical applications, including dye synthesis and epoxy curing agents [5] Group 3: Project Progress and Performance - Two fundraising projects commenced construction at the end of December 2024, with an 18-month construction period; one project aims for an annual output of 10,000 tons of thermoplastic polyurethane elastomers, and the other for 30,000 tons of water-based polyurethane [6] - The company's third-quarter performance will be influenced by market demand, raw material prices, and operational factors, with specific results to be detailed in the quarterly report [7]

Core Viewpoint - Meirui New Materials announced the approval of several proposals, including the convening of the first extraordinary shareholders' meeting in 2025 by the eighth meeting of the fourth board of directors [2] Group 1 - The company held its eighth meeting of the fourth board of directors on September 8 [2] - The meeting approved the proposal to convene the first extraordinary shareholders' meeting in 2025 [2]

Group 1 - Meirui New Materials (SZ 300848) announced on September 8 that its fourth board meeting was held to discuss the proposal for capital increase in its controlling subsidiary and related transactions [1] - For the year 2024, the revenue composition of Meirui New Materials is 100.0% from the manufacturing of chemical raw materials and chemical products [1] - As of the report date, Meirui New Materials has a market capitalization of 7.1 billion yuan [1] Group 2 - The article highlights the significant growth of China's innovative pharmaceutical industry, noting a shift in trust from multinational pharmaceutical companies towards Chinese data [1]

中德证券有限责任公司 关于美瑞新材料股份有限公司 拟对控股子公司增资暨关联交易进展事项的核查意见 中德证券有限责任公司（以下简称"中德证券"或"保荐机构"）作为美瑞 新材料股份有限公司（以下简称"美瑞新材"或"公司"）持续督导保荐机构， 根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等有关规定，对公司拟对控股子公司增资暨关联交易进展事项进行了核查，具体 情况如下： 一、 公司向控股子公司增资暨关联交易概述 根据公司整体战略发展规划与业务发展需要，美瑞新材已于 2025 年 8 月 23 日分别召开第四届董事会独立董事专门会议第四次会议、第四届董事会第七次会 议，审议通过了《关于拟对控股子公司增资暨关联交易的议案》，同意公司向控 股子公司美瑞科技（河南）有限公司（以下简称"美瑞科技"）进行最高不超过 35,000 万元人民币的增资，最终增资额以增资协议签署内容为准。美瑞科技其余 股东均确认放弃本次增资的优先认缴权。本次增资完成后，美瑞科技仍为公司的 控股子公司，继续纳入公司合并报表范围。 由于美瑞科技的股东之 ...

证券代码：300848 证券简称：美瑞新材 公告编号：2025-070 美瑞新材料股份有限公司 关于拟对控股子公司增资暨关联交易进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、公司向控股子公司增资暨关联交易概述 根据美瑞新材料股份有限公司（以下简称"公司"）整体战略发展规划与业务发展需 要，公司已于 2025 年 8 月 23 日分别召开第四届董事会独立董事专门会议第四次会议、第 四届董事会第七次会议，审议通过了《关于拟对控股子公司增资暨关联交易的议案》，同 意公司向控股子公司美瑞科技（河南）有限公司（以下简称"美瑞科技"）进行最高不超 过 35,000 万元人民币的增资，最终增资额以增资协议签署内容为准。美瑞科技其余股东均 确认放弃本次增资的优先认缴权。本次增资完成后，美瑞科技仍为公司的控股子公司，继 续纳入公司合并报表范围。 由于美瑞科技的股东之一为青岛瑞华投资合伙企业（有限合伙）（以下简称"青岛瑞 华"），公司实际控制人王仁鸿先生持有其 59.33%的合伙份额，并担任其执行事务合伙人， 根据《深圳证券交易所创业板股票上市规则》等规定，青岛 ...

证券代码：300848 证券简称：美瑞新材 公告编号：2025-073 美瑞新材料股份有限公司 关于召开 2025 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 美瑞新材料股份有限公司(以下简称"公司")第四届董事会第八次会议审议通过了 《关于召开 2025 年第一次临时股东会的议案》，决定于 2025 年 9 月 24 日（星期三）召开 公司 2025 年第一次临时股东会，现将本次股东会的有关事项通知如下： 一、本次股东会召开的基本情况 1、股东会届次：2025 年第一次临时股东会 2、股东会召集人：公司董事会 3、会议召开的合法、合规性：经公司第四届董事会第八次会议审议通过，决定召开 2025 年第一次临时股东会，召集程序符合有关法律、行政法规、部门规章、规范性文件和公司 章程的规定。 4、会议召开的日期、时间： 现场会议时间：2025 年 9 月 24 日（星期三）14:30 网络投票时间：2025 年 9 月 24 日 其中，通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 9 月 24 日的交易 时间，即 9: ...

美瑞新材料股份有限公司 第四届董事会独立董事专门会议第五次会议决议公告 本公司及全体独立董事保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 二、会议审议情况 经与会独立董事认真审议，形成决议如下: 1、审议通过《关于拟对控股子公司增资暨关联交易进展的议案》 经审核，独立董事认为：本次增资暨关联交易事宜符合控股子公司美瑞科技经营发展 需要，符合公司及控股子公司的战略规划，不会影响公司的合并报表范围。涉及的关联交 易是以第三方资产评估机构评估的评估结果为基础进行定价，该定价公平、合理、公允， 不存在损害公司及全体股东特别是中小投资者利益的情形。因此，独立董事一致同意将本 次增资暨关联交易进展事项提交给董事会审议，根据法律、法规和《公司章程》等相关规 则和制度的规定，关联董事应回避表决。 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）的《关于拟对控股子 公司增资暨关联交易进展的公告》。 表决结果：3 票同意，0 票反对，0 票弃权。 三、备查文件 一、会议召开情况 美瑞新材料股份有限公司（以下简称"公司"）第四届董事会独立董事专门会议第五 次会议于 2025 ...